Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor.
about
Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome.Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor.Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival.Molecular diagnostics in embryonal brain tumors.Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies.Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007.The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.Molecular diagnostics of CNS embryonal tumors.Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors.Ethical considerations surrounding germline next-generation sequencing of children with cancer.Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.The tyrosine kinase c-Abl promotes proliferation and is expressed in atypical teratoid and malignant rhabdoid tumors.High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB).Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism.Rapid Diagnosis of an AT/RT by the Detection of a Heterozygous SMARCB1 Germ Line Deletion in an Infant.Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database.Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS).Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).High sensitivity of FISH analysis in detecting homozygous SMARCB1 deletions in poorly differentiated chordoma: a clinicopathologic and molecular study of nine cases.Atypical teratoid/rhabdoid tumor arising in a malignant glioma.Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous.Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22.Atypical Teratoid Rhabdoid Tumour : From Tumours to Therapies.Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: A report of the SIOP renal tumour study groupIn Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an Example
P2860
Q33645991-99025950-8384-44A7-A87A-6C4F40EF45F2Q34627709-482AF0C7-EC71-4C5A-8BB7-2CC6698344F3Q34915348-35EF907A-B8D7-48A2-8B2E-D491A9180169Q35570270-8D9D39C1-627D-4A09-93A9-F964A344829EQ36619093-9DBCE6FD-96C9-46F6-B1FE-F55837EB03CEQ36893203-C62923A8-3913-4F66-B623-5EF3E67C283DQ36945821-4BBAF492-F7D2-4059-9E80-60F5DCEBB25DQ37601480-63F74F88-B607-419D-9FB0-CD4A69930CE5Q37794829-BA0951F0-560D-45E1-9455-A1E045D61044Q37969710-A244E43A-D9F9-4B4B-8D7B-A66CC9C2407BQ38400410-A895C7AE-557B-46E6-A2ED-5503C285C160Q38880725-950418E7-FB73-49EE-9594-2EB5F0C4A234Q39003338-6589D361-2B14-4DA2-A2F8-AEC5EE7D9815Q39235246-47BF5EAC-D076-4925-B643-49EAF013CD41Q39629867-ED941AF1-0760-4F43-A65C-6B6B0E7FC0A4Q39680458-9F93ABF6-68DD-4411-BD14-D4383EC61D2BQ40163705-F2CAFA1E-15E3-4BB8-B76E-5A7FCA7CF697Q40570465-1562A674-2C2F-4DBE-8537-A5B52D75D18AQ40792505-10759157-C2CE-4DFA-BD31-00DD6DDDCCDFQ43944813-9D66E74E-BC54-4D22-9EC0-F910FD325D7AQ45382547-7F1F4CFD-54AC-494D-A9CC-7773F62CDA48Q47261738-CE517677-4F68-4014-8596-FAAE69624152Q48336422-8A9AEDDD-E2E0-4F11-B40C-E2008F904846Q48596705-02427A66-B884-42AD-BECE-C78FAE4E9031Q50079534-F13C2759-4076-4EEC-B506-A1DC026E9CFAQ50145215-93A7FFA3-D791-472D-9B71-05847357A64EQ52118908-95F1CD67-C0F2-4B45-B501-6E126D1FC8E9Q55102629-CEFC84F7-2657-4A01-B63E-5FEFA72E08D3Q57339568-49E66139-D7DE-4914-95B9-BF4FBE535A59Q58772664-0D24F344-FE04-476C-9ECF-B8EAB5E0785B
P2860
Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Clinical and molecular feature ...... r or malignant rhabdoid tumor.
@en
Clinical and molecular feature ...... r or malignant rhabdoid tumor.
@nl
type
label
Clinical and molecular feature ...... r or malignant rhabdoid tumor.
@en
Clinical and molecular feature ...... r or malignant rhabdoid tumor.
@nl
prefLabel
Clinical and molecular feature ...... r or malignant rhabdoid tumor.
@en
Clinical and molecular feature ...... r or malignant rhabdoid tumor.
@nl
P2093
P2860
P50
P356
P1476
Clinical and molecular feature ...... r or malignant rhabdoid tumor.
@en
P2093
Astrid Jeibmann
Ivo Leuschner
Michael Christoph Frühwald
Ove Peters
Stefan Gesk
Torsten Pietsch
Uwe Kordes
P2860
P304
P356
10.1002/GCC.20729
P577
2010-02-01T00:00:00Z